Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1423537
PUBLISHER: BCC Research | PRODUCT CODE: 1423537
Global Markets and Technologies for Advanced Drug Delivery Systems
PUBLISHED:
PAGES: 265 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Highlights:
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
North American market for advanced drug delivery systems is expected to increase from $109.4 billion in 2023 to $152.1 billion by the end of 2028, with a CAGR of 6.8% during the forecast period of 2023-2028.
Asia-Pacific market for advanced drug delivery systems is expected to increase from $47.7 billion in 2023 to $68.6 billion by the end of 2028, with a CAGR of 7.5% during the forecast period of 2023-2028.
Report Scope:
This report aims to provide a comprehensive study of the global market for advanced drug delivery systems (ADDS) and processes, both in terms of quantitative and qualitative data, to help people and companies develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions about drug deliveries.
This in-depth analysis of the global ADDS market includes historical data and market projections on sales by technology, route of administration, drug vehicles/carriers and application. The analysis describes the different types of ADDS technology (immediate-release drug delivery, extended-release drug delivery, targeted-release drug delivery, delayed-release drug delivery, and pulsatile-release drug delivery) and their current and historical market revenues. It also covers the route of administration of a drug delivery system and the source of a carrier mechanism for drug delivery. In addition, the report examines applications of ADDS (oncology, respiratory, inflammatory and allergies, cardiovascular, ophthalmic, central nervous system, hormone replacement therapy and gynecology, viral and bacterial diseases, diabetes, urology, gastrointestinal disorders, dermatology, other).
The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different industries.
Report Includes:
- 27 data tables and 93 additional tables
- An overview of the global markets and technologies for advanced drug delivery systems (ADDS)
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the market size and revenue forecast for the global ADDS market, and corresponding market share analysis based on technology, application (therapeutic area), route of administration, vehicle/carrier of drugs mechanism and geographic region
- Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
- Discussion of the importance of ESG in the ADDS market, including consumer attitudes, impact of ESG factors on company performance and ESG practices of leading companies
- Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
- Insight into the emerging technologies and developments in the ADDS market and clinical trial landscape
- An analysis of the industry structure, including company market shares, recent M&A activity and venture funding
- Analysis of the competitive landscape based on recent developments and the segmental revenues of leading vendors
- Company profiles of major players within the industry, including Johnson & Johnson, Novartis AG, Pfizer Inc., Merck & Co. Inc., Medtronic, and Abbott.
Product Code: PHM006N
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- What's New in this Update?
- Methodology
- Information Sources
- Geographic Breakdown
- Segmentation Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Highlights of the Market for Advanced Drug Delivery Systems
Chapter 3 Market Overview
- Overview
- Evolution of Advanced Drug Delivery Systems
Chapter 4 Market Dynamics
- Overview
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of COVID-19 on the ADDS Market
Chapter 5 Evaluation of the Market Based on Technology
- Overview of Advanced Drug Delivery Systems and Technologies
- Market Share and Forecast
- Immediate-Release Drug Delivery
- Extended-Release Drug Delivery
- Targeted-Release Drug Delivery
- Delayed-Release Drug Delivery
- Pulsatile-Release Drug Delivery
Chapter 6 Evaluation of the Market Based on Route of Administration
- Overview of Routes of Administration of Drugs
- Market Share and Forecast
- Oral
- Parenteral/Injectable
- Transmucosal
- Transmucosal Nasal and Pulmonary
- Transmucosal Ocular
- Transmucosal Rectal
- Transmucosal Oral Buccal
- Transmucosal Vaginal
- Implant
- Transdermal
- Topical
Chapter 7 Evaluation of the Market Based on Vehicle/Carrier
- Overview of Vehicles/Carriers Used in Advanced Drug Delivery Systems
- Market Share and Forecast
- Nanoparticles
- Monoclonal Antibodies
- Liposomes
- Polymeric Therapeutics
- Dendrimers
- Polymeric Drug
- Polymeric Micelles
- Prodrugs
- Microparticles
- Others
Chapter 8 Evaluation of the Market Based on Application
- Overview of Applications Used in Advanced Drug Delivery Systems
- Market Share and Forecast
- Oncology
- Inflammatory Diseases and Allergies
- Cardiovascular
- Ophthalmic
- Central Nervous System
- Hormone Replacement Therapy and Gynecology
- Viral and Bacterial Diseases
- Diabetes
- Urology
- Gastrointestinal (GI) Disorders
- Dermatology
- Respiratory
- Other Therapeutic
Chapter 9 Evaluation of the Market Based on Geographic Region
- Global Market for ADDS by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 10 ESG Development
- Introduction to ESG
- Sustainability in the Advanced Drug Delivery Systems (ADDS) Industry: An ESG Perspective
- Key ESG Issues
- ESG Risk Rankings
- Consumer Attitudes toward ESG in the ADDS Market
- Case Study
- Concluding Remarks from BCC
Chapter 11 Emerging Technologies in the Market
- Emerging Technology, ADDS Market
- 3D Printing Technology in Drug Delivery
- Biologics Drug Delivery
- AI in Drug Delivery
- Smart Drug Delivery System
Chapter 12 Clinical Trials and Patent Analysis
- Clinical Trials Analysis
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis by Status
- Clinical Trials Analysis by Phase
- Clinical Trials Analysis by Region
- Patent Analysis
- Patents by Year
- Patents by Top Applicant
- Patents by Top Owner
- Patents by Jurisdiction
Chapter 13 Competitive Intelligence
- Market Share Analysis
- Recent Developments of Key Market Players
Chapter 14 Company Profiles
- ABBOTT
- ABBVIE INC.
- ASTRAZENECA
- BD
- BOSTON SCIENTIFIC CORP.
- F. HOFFMANN-LA ROCHE LTD
- JOHNSON & JOHNSON SERVICES INC.
- KINDEVA DRUG DELIVERY
- MEDTRONIC
- MERCK & CO. INC.
- NOVARTIS AG
- PFIZER INC.
- SANOFI S.A.
- TERUMO CORP.
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
Chapter 15 Appendix: Acronyms
Product Code: PHM006N
List of Tables
- Summary Table A : Global Market for Advanced Drug Delivery Systems, by Technology, Through 2028
- Summary Table B : Global Market for Advanced Drug Delivery Systems, by Region, Through 2028
- Table 1 : Global Market for Advanced Drug Delivery Systems, by Technology, Through 2028
- Table 2 : Main Orally Disintegrating Drug Delivery Technologies
- Table 3 : Comparison of Different Orally Disintegrating Drug Delivery Technologies
- Table 4 : Drugs Qualified for Fast-Dissolving Tablet
- Table 5 : Examples of Drugs Using Orally Disintegrating Drug Delivery Technologies
- Table 6 : List of Commercially Available Fast Dissolving Tablets (FDTs)
- Table 7 : List of Commercially Available Fast Dissolving Oral Films
- Table 8 : Difference Between Sustained vs. Controlled Drug Delivery
- Table 9 : Classic Methods of Extended-Release Delivery Systems and Their Limitations
- Table 10 : Examples of Companies Developing Extended Drug Delivery Systems
- Table 11 : Global Market for Extended-Release Drug Delivery Systems, by Type, Through 2028
- Table 12 : Examples of Delivery Carriers for Targeted Drug Delivery Systems
- Table 13 : Examples of FDA-Approved ADC Drugs
- Table 14 : Examples of Current U.S. FDA-Approved Nanoparticles and Type of Targeting Employed, Indications, Advantages and Drawbacks
- Table 15 : Examples of Companies Developing Targeted Drug Delivery Systems
- Table 16 : Examples of Diseases that Require Pulsatile Drug Delivery Systems
- Table 17 : Examples of FDA-Approved Advanced Pulsatile Drug Delivery Systems
- Table 18 : Examples of Pulsatile Drug Delivery Systems on the Market and the Market Players That Developed Them
- Table 19 : Advantages and Disadvantages of Different Routes of Drug Administration
- Table 20 : Global Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2028
- Table 21 : Some Oral Advanced Drug Delivery Systems
- Table 22 : Examples of Specialized Parenteral Routes of Administration
- Table 23 : Transmucosal Drug Delivery
- Table 24 : Global Market for Advanced Transmucosal Drug Delivery Systems, by Type, Through 2028
- Table 25 : Global Market for Advanced Transmucosal Nasal and Pulmonary Drug Delivery Systems, Through 2028
- Table 26 : Examples of Hydrogels and Composites Developed for Ocular Drug Delivery
- Table 27 : Global Market for Advanced Ocular Advanced Drug Delivery Systems, Through 2028
- Table 28 : Examples of Rectal Formulations Clinically Approved
- Table 29 : Global Market for Advanced Rectal Advanced Drug Delivery Systems, Through 2028
- Table 30 : Examples of Marketed Medications Delivered, by the Oral-Buccal Route of Administration
- Table 31 : Global Market for Advanced Oral Buccal Drug Delivery Systems, Through 2028
- Table 32 : Global Market for Advanced Vaginal Drug Delivery Systems, Through 2028
- Table 33 : Examples of Implantable Drug Devices on the Market
- Table 34 : FDA-Approved Transdermal Patches
- Table 35 : Types of Topical Medications
- Table 36 : Examples of Advanced Topical Drug Delivery Systems In Clinical Use
- Table 37 : Global Market for Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, Through 2028
- Table 38 : Examples of Nanocarriers in Drug Delivery and Their Characteristics
- Table 39 : Examples of FDA-Approved Nanodrugs Available for Clinical Use
- Table 40 : Examples of Clinically Approved Liposome-Based Therapeutics on the Market
- Table 41 : Some Liposomal Products Approved, by FDA and EMA
- Table 42 : Global Market for Polymeric Therapeutics for Advanced Drug Delivery Devices, Through 2028
- Table 43 : Examples of Dendrimer-Drug Interactions in Cancer Therapy
- Table 44 : Examples of Polymer Drugs Commercially Available
- Table 45 : Global Market Shares of Advanced Drug Delivery Systems, by Type of Polymeric Drug, 2022
- Table 46 : Examples of Stimuli-Responsive Polymeric Micelles for Cancer Therapy
- Table 47 : Examples of FDA-Approved Prodrugs on the Market
- Table 48 : Comparison of Control Release Devices
- Table 49 : Ten Leading Causes of Death Globally, 2021
- Table 50 : Global Market for Advanced Drug Delivery Systems, by Application, Through 2028
- Table 51 : Worldwide Cancer Incidence, by Type, 2020
- Table 52 : Examples of Different Systems Used in the Cardiovascular Delivery of Therapeutics
- Table 53 : Examples of Ophthalmology Drug Delivery Systems
- Table 54 : Examples of Marketed Nanopharmaceuticals for Brain Disorders
- Table 55 : Examples of Nanoplatforms for Drug Delivery Approved, by the FDA, EMA and Other Organizations
- Table 56 : Examples of Antibacterial Drug Delivery Systems
- Table 57 : Key Facts and Latest Data for Diabetes Globally, 2021 and 2045
- Table 58 : Commercially Available Insulin Injector Pens & Manufacturers
- Table 59 : Examples of Drug Delivery Systems for Diabetes Treatment
- Table 60 : Prevalence of End Stage Renal Disease, by Country, 2020
- Table 61 : Examples of Gastro-Retentive Products Available in the Market
- Table 62 : Global Market for Advanced Drug Delivery Systems, by Region, Through 2028
- Table 63 : Cancer Incidence in Europe, by Select Countries, 2022
- Table 64 : ESG: Environmental Overview
- Table 65 : ESG: Social Overview
- Table 66 : ESG: Governance Overview
- Table 67 : ESG Rankings for Major ADDS Companies, 2023*
- Table 68 : Research Projects Using 3D Printing Techniques to Design Drug Delivery Systems
- Table 69 : List of Smart Drug Delivery Systems
- Table 70 : Clinical Trials in Drug Delivery System, by Type of Study, as of November 2023
- Table 71 : Clinical Trials in Drug Delivery System, by Status, as of November 2023
- Table 72 : Clinical Trials in Drug Delivery System, by Phase, as of November 2023
- Table 73 : Clinical Trials in Drug Delivery System, by Region, November 2023
- Table 74 : Patents Granted for Drug Delivery Systems, by Top Applicant, 2018-2022
- Table 75 : Patents Granted for Drug Delivery Systems, by Top Owner, 2018-2022
- Table 76 : Patents Granted for Drug Delivery Systems, by Jurisdiction, 2018-2022
- Table 77 : Advanced Drug Delivery Systems: Market Player Ranking
- Table 78 : Recent Developments in Global Market for Advanced Drug Delivery Systems, 2020-2023
- Table 79 : Abbott: Company Snapshot
- Table 80 : Abbott: Financials, 2021 and 2022
- Table 81 : Abbott: Product Portfolio
- Table 82 : Abbott: Key Developments, 2021
- Table 83 : AbbVie Inc.: Company Snapshot
- Table 84 : AbbVie Inc.: Financials, 2021 and 2022
- Table 85 : AbbVie Inc.: Key Developments, 2020
- Table 86 : AstraZeneca: Company Snapshot
- Table 87 : BD: Company Snapshot
- Table 88 : BD: Financials, 2021 and 2022
- Table 89 : BD: Product Portfolio
- Table 90 : BD: Key Developments, 2021-2023
- Table 91 : Boston Scientific Corp.: Company Snapshot
- Table 92 : Boston Scientific Corp.: Financials, 2021 and 2022
- Table 93 : Boston Scientific Corp.: Product Portfolio
- Table 94 : Boston Scientific Corp.: Key Developments, 2022
- Table 95 : F. Hoffmann-La Roche Ltd.: Company Snapshot
- Table 96 : F. Hoffmann-La Roche Ltd.: Financials, 2021 and 2022
- Table 97 : Johnson & Johnson Services Inc.: Company Snapshot
- Table 98 : Johnson & Johnson Services Inc.: Financials, 2021 and 2022
- Table 99 : Johnson & Johnson Services Inc.: Key Developments, 2022
- Table 100 : Kindeva Drug Delivery: Company Snapshot
- Table 101 : Medtronic plc: Company Snapshot
- Table 102 : Medtronic plc: Financials, 2021 and 2022
- Table 103 : Medtronic plc: Product Portfolio
- Table 104 : Medtronic plc: Key Developments, 2023
- Table 105 : Merck & Co. Inc.: Company Snapshot
- Table 106 : Merck & Co. Inc.: Financials, 2021 and 2022
- Table 107 : Novartis AG: Company Snapshot
- Table 108 : Novartis AG: Financials, 2021 and 2022
- Table 109 : Novartis AG: Key Developments, 2020-2022
- Table 110 : Pfizer Inc.: Company Snapshot
- Table 111 : Pfizer Inc.: Financials, 2021 and 2022
- Table 112 : Sanofi S.A.: Company Snapshot
- Table 113 : Sanofi S.A.: Financials, 2021 and 2022
- Table 114 : Terumo Corp.: Company Snapshot
- Table 115 : Terumo Corp.: Product Portfolio
- Table 116 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
- Table 117 : Teva Pharmaceutical Industries Ltd.: Financials, 2021 and 2022
- Table 118 : Acronyms Used in This Report
List of Figures
- Summary Figure A : Global Market for Advanced Drug Delivery Systems, by Technology, 2020-2028
- Summary Figure B : Global Market for Advanced Drug Delivery Systems, by Region, 2020-2028
- Figure 1 : Conventional vs. Advanced Drug Delivery
- Figure 2 : Conventional vs. Advanced Dosage Forms
- Figure 3 : Evolution of Advanced Drug Delivery System, Since 1950s
- Figure 4 : Global Markets and Technologies for Advanced Drug Delivery Systems Market Dynamics
- Figure 5 : Categories of Therapeutic and Delivery Approaches
- Figure 6 : Global Market for Advanced Drug Delivery Systems, by Technology
- Figure 7 : Global Market Shares of Advanced Drug Delivery Systems, by Technology, 2022
- Figure 8 : Global Market for Immediate Drug Release Technology, 2020-2028
- Figure 9 : Extended Drug Delivery, by Type
- Figure 10 : Global Market for Extended-Release Drug Delivery Systems, 2020-2028
- Figure 11 : Global Market for Extended-Release Drug Delivery Systems, by Type, 2020-2028
- Figure 12 : Global Market for Targeted-Release Drug Delivery Systems, 2020-2028
- Figure 13 : Global Market for Delayed-Release Drug Delivery Systems, 2020-2028
- Figure 14 : Global Market for Pulsatile Release Drug Delivery Systems, 2020-2028
- Figure 15 : Global Market Shares of Advanced Drug Delivery Systems, by Route of Administration, 2022
- Figure 16 : Oral Drug Delivery: Market Overview
- Figure 17 : Global Market for Oral Advanced Drug Delivery Systems, 2020-2028
- Figure 18 : Global Market for Parenteral/Injectable Advanced Drug Delivery Systems, 2020-2028
- Figure 19 : Global Market for Advanced Transmucosal Drug Delivery Systems, 2020-2028
- Figure 20 : Global Market for Advanced Transmucosal Drug Delivery Systems, by Type, 2020-2028
- Figure 21 : Global Market for Advanced Implant Drug Delivery Systems, 2020-2028
- Figure 22 : Global Market for Advanced Transdermal Drug Delivery Systems, 2020-2028
- Figure 23 : Global Market for Advanced Topical Drug Delivery Systems, 2020-2028
- Figure 24 : Global Market Shares of Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, 2022
- Figure 25 : Global Market for Nanoparticles for Advanced Drug Delivery Systems, 2020-2028
- Figure 26 : Global Market for Monoclonal Antibodies for Advanced Drug Delivery Devices, 2020-2028
- Figure 27 : Global Market for Liposomes for Advanced Drug Delivery Systems, 2020-2028
- Figure 28 : Global Market for Polymeric Therapeutics for Advanced Drug Delivery Systems, 2020-2028
- Figure 29 : Global Market for Polymeric Therapeutics for Advanced Drug Delivery Devices, 2020-2028
- Figure 30 : Global Market Shares of Advanced Drug Delivery Systems, by Type of Polymeric Drugs, 2022
- Figure 31 : Global Market for Prodrugs for Advanced Drug Delivery Devices, 2020-2028
- Figure 32 : Global Market for Microparticles/Microspheres for Advanced Drug Delivery Devices, 2020-2028
- Figure 33 : Global Market for Other Drug Delivery Vehicles/Carriers for Advanced Drug Delivery Systems, 2020-2028
- Figure 34 : Global Market Shares of Advanced Drug Delivery Systems, by Application, 2022
- Figure 35 : Global Market for Advanced Drug Delivery Systems in Oncology Applications, 2020-2028
- Figure 36 : Global Market for Advanced Drug Delivery Systems in Inflammatory and Allergy Applications, 2020-2028
- Figure 37 : Global Market for Advanced Drug Delivery Systems in Cardiovascular Applications, 2020-2028
- Figure 38 : Global Market for Advanced Drug Delivery Systems in Ophthalmic Applications, 2020-2028
- Figure 39 : Global Market for Advanced Drug Delivery Systems in Central Nervous System Applications, 2020-2028
- Figure 40 : Global Market for Advanced Drug Delivery Systems in Hormone Replacement Therapy and Gynecological Applications, 2020-2028
- Figure 41 : Influenza Burden Estimates in the U.S., October 2022 to April 2023
- Figure 42 : Global Market for Advanced Drug Delivery Systems in Viral and Bacterial Diseases Applications, 2020-2028
- Figure 43 : Global Market for Advanced Drug Delivery Systems in Diabetes Applications, 2020-2028
- Figure 44 : Global Market for Advanced Drug Delivery Systems in Urology Applications, 2020-2028
- Figure 45 : Global Market for Advanced Drug Delivery Systems in Gastrointestinal Disorder Applications, 2020-2028
- Figure 46 : Global Market for Advanced Drug Delivery Systems in Dermatology Applications, 2020-2028
- Figure 47 : Global Market for Advanced Drug Delivery Systems in Respiratory Applications, 2020-2028
- Figure 48 : Global Market for Advanced Drug Delivery Systems in Other Therapeutic Applications, 2020-2028
- Figure 49 : Global Market Shares of Advanced Drug Delivery Systems, by Region, 2022
- Figure 50 : North American Market for Advanced Drug Delivery Systems, 2020-2028
- Figure 51 : European Market for Advanced Drug Delivery Systems, 2020-2028
- Figure 52 : Asia-Pacific Market for Advanced Drug Delivery Systems, 2020-2028
- Figure 53 : Rest of the World Market for Advanced Drug Delivery Systems, 2020-2028
- Figure 54 : ESG Pillars
- Figure 55 : Advantages of ESG for Biopharmaceutical Companies
- Figure 56 : ESG-Adoption Level Across All the Industries, Global, 2021 and 2022
- Figure 57 : Hospitals: Sustainability Priorities
- Figure 58 : Novartis: Major ESG Activities, 2022
- Figure 59 : Patents Granted for Drug Delivery Systems, by Year, 2018-2022
- Figure 60 : Major Pharmaceutical Players in the ADDS Market
- Figure 61 : Major Medical Device Players in the ADDS Market
- Figure 62 : Major CDMO Players in the ADDS Market
- Figure 63 : Major CDMO Players in the ADDS Market
- Figure 64 : Abbott: Revenue Share, by Business Unit, 2022
- Figure 65 : Abbott: Revenue Share, by Region, 2022
- Figure 66 : AbbVie Inc.: Financials, 2021 and 2022
- Figure 67 : AbbVie Inc.: Revenue Share, by Business Unit, 2022
- Figure 68 : AbbVie Inc.: Revenue Share, by Region, 2022
- Figure 69 : BD: Financials, 2021 and 2022
- Figure 70 : BD: Revenue Share, by Business Unit, 2022
- Figure 71 : BD: Revenue Share, by Region, 2022
- Figure 72 : Boston Scientific Corp.: Financials, 2021 and 2022
- Figure 73 : Boston Scientific Corp.: Revenue Share, by Business Unit, 2022
- Figure 74 : Boston Scientific Corp.: Revenue Share, by Country/Region, 2022
- Figure 75 : F. Hoffmann-La Roche Ltd.: Financials, 2021 and 2022
- Figure 76 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, 2022
- Figure 77 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2022
- Figure 78 : Johnson & Johnson Services Inc.: Financials, 2021 and 2022
- Figure 79 : Johnson & Johnson Services Inc.: Revenue Share, by Business Segment, 2022
- Figure 80 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, 2022
- Figure 81 : Medtronic plc: Financials, 2021 and 2022
- Figure 82 : Medtronic plc: Market Share, by Business Unit, 2022
- Figure 83 : Medtronic plc: Market Share, by Region, 2022
- Figure 84 : Merck & Co. Inc.: Financials, 2021 and 2022
- Figure 85 : Merck & Co. Inc.: Revenue Share, by Business Unit, 2022
- Figure 86 : Merck & Co. Inc.: Revenue Share, by Country/Region, 2022
- Figure 87 : Novartis AG: Financials, 2021 and 2022
- Figure 88 : Novartis AG: Revenue Share, by Business Unit, 2022
- Figure 89 : Novartis AG: Revenue Share, by Region, 2022
- Figure 90 : Pfizer Inc.: Financials, 2021 and 2022
- Figure 91 : Pfizer Inc.: Revenue Share, by Business Unit, 2022
- Figure 92 : Pfizer Inc.: Revenue Share, by Region, 2022
- Figure 93 : Sanofi S.A.: Financials, 2021 and 2022
- Figure 94 : Sanofi S.A.: Revenue Share, by Business Unit, 2022
- Figure 95 : Sanofi S.A.: Revenue Share, by Region, 2022 (%)
- Figure 96 : Teva Pharmaceutical Industries Ltd.: Financials, 2021 and 2022
- Figure 97 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Unit, 2022
- Figure 98 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2022
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.